Early microvascular reactions and blood–spinal cord barrier disruption are instrumental in pathophysiology of spinal cord injury and repair: novel therapeutic strategies including nanowired drug delivery to enhance neuroprotection

2010 ◽  
Vol 118 (1) ◽  
pp. 155-176 ◽  
Author(s):  
Hari Shanker Sharma
IBRO Reports ◽  
2019 ◽  
Vol 6 ◽  
pp. S359-S360
Author(s):  
Chan Sol Park ◽  
Jee Youn Lee ◽  
Hae Young Choi ◽  
Tae Young Yune

2016 ◽  
Vol 54 (5) ◽  
pp. 3578-3590 ◽  
Author(s):  
Hemant Kumar ◽  
Alexander E. Ropper ◽  
Soo-Hong Lee ◽  
Inbo Han

2015 ◽  
Vol 18 (5) ◽  
pp. 293-295 ◽  
Author(s):  
Hou-Qing Long ◽  
Guang-Sheng Li ◽  
Xing Cheng ◽  
Jing-Hui Xu ◽  
Fo-Bao Li

2021 ◽  
Vol 12 ◽  
Author(s):  
Zhou Feng ◽  
Lingxia Min ◽  
Liang Liang ◽  
Beike Chen ◽  
Hui Chen ◽  
...  

As the first inflammatory cell recruited to the site of spinal cord injury (SCI), neutrophils were reported to be detrimental to SCI. However, the precise mechanisms as to how neutrophils exacerbate SCI remain largely obscure. In the present study, we demonstrated that infiltrated neutrophils produce neutrophil extracellular traps (NETs), which subsequently promote neuroinflammation and blood–spinal cord barrier disruption to aggravate spinal cord edema and neuronal apoptosis following SCI in rats. Both inhibition of NETs formation by peptidylarginine deiminase 4 (PAD4) inhibitor and disruption of NETs by DNase 1 alleviate secondary damage, thus restraining scar formation and promoting functional recovery after SCI. Furthermore, we found that NETs exacerbate SCI partly via elevating transient receptor potential vanilloid type 4 (TRPV4) level in the injured spinal cord. Therefore, our results indicate that NETs might be a promising therapeutic target for SCI.


Sign in / Sign up

Export Citation Format

Share Document